Apotex Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APOTEX CORP
APOTEX CORP has thirteen approved drugs.
There are two tentative approvals on APOTEX CORP drugs.
Summary for Apotex Corp
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 13 |
| Patent Litigation for Apotex Corp: | See patent lawsuits for Apotex Corp |
| PTAB Cases with Apotex Corp as petitioner: | See PTAB cases with Apotex Corp as petitioner |
Drugs and US Patents for Apotex Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Corp | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 218745-001 | Aug 19, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Apotex Corp | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200878-003 | Apr 20, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Apotex Corp | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 200164-001 | Sep 25, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Apotex Corp | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 091379-001 | Nov 6, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Apotex Corp | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 091373-002 | Apr 22, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Apotex Corp | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 200164-002 | Sep 25, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Apotex Corp | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 091373-001 | Apr 22, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
